| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.076 | 0.2 |